Tobacco Use Behaviors and Associated Factors among Newly Diagnosed Tuberculosis Patients in Benin and Burkina Faso.

Autor: Ouédraogo AR; Service de Pneumologie, Centre Hospitalier et Universitaire de Tengandogo (CHU-T), Ouagadougou P.O. Box 104, Burkina Faso.; Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo, Ouagadougou P.O. Box 7021, Burkina Faso.; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France., Fiogbé AA; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France.; National Tuberculosis Programme, Cotonou P.O. Box 321, Benin.; Service de Pneumologie, Centre National et Universitaire de Pneumo-Phitsiologie de Cotonou (CNHUPP/C), Cotonou P.O. Box 321, Benin., Menon S; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France.; Epitech Research, 1160 Auderghem, Belgium., Esse MA; National Tuberculosis Programme, Cotonou P.O. Box 321, Benin., Saouadogo T; National Tuberculosis Programme, Ouagadougou P.O. Box 6632, Burkina Faso., Daouda A; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France., Combary A; National Tuberculosis Programme, Ouagadougou P.O. Box 6632, Burkina Faso., Agodokpessi G; National Tuberculosis Programme, Cotonou P.O. Box 321, Benin.; Service de Pneumologie, Centre National et Universitaire de Pneumo-Phitsiologie de Cotonou (CNHUPP/C), Cotonou P.O. Box 321, Benin., Ouédraogo G; Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo, Ouagadougou P.O. Box 7021, Burkina Faso.; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France.; Service de Pneumologie, Centre Hospitalier et Universitaire de Yalgado Ouédraogo (CNHU-YO), Ouagadougou P.O. Box 7022, Burkina Faso., Badoum G; Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo, Ouagadougou P.O. Box 7021, Burkina Faso.; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France.; Service de Pneumologie, Centre Hospitalier et Universitaire de Yalgado Ouédraogo (CNHU-YO), Ouagadougou P.O. Box 7022, Burkina Faso., Lin Y; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France., Koura KG; International Union Against Tuberculosis and Lung Disease, 75001 Paris, France.; COMUE Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes, 75006 Paris, France.
Jazyk: angličtina
Zdroj: Tropical medicine and infectious disease [Trop Med Infect Dis] 2024 May 22; Vol. 9 (6). Date of Electronic Publication: 2024 May 22.
DOI: 10.3390/tropicalmed9060120
Abstrakt: The objective of this study was to assess tobacco use (TU) behaviors among newly diagnosed pulmonary TB (PTB) patients and identify associated factors in Benin and Burkina Faso. A cross-sectional study was conducted in 20 randomly selected TB clinics. To ensure a representative study cohort, clinics were stratified during the sampling process. PTB patients were consecutively sampled in 20 of the clinics between 1 December 2021 and 30 September 2022. The study population comprised individuals aged 15 years and above who were newly diagnosed with PTB. Among the 1399 registered PTB patients, 564 (40.3%) reported a history of TU, including 392 (28.0%) current tobacco users and 172 ex-tobacco users. Cigarettes emerged as the predominant form of TU (86.2%), followed by smokeless tobacco (6.4%), and chicha smoking (2.6%). Factors independently associated with tobacco use were male gender ( p < 0.001), being in Burkina Faso ( p < 0.001), and an age of 25-59 years ( p = 0.002). Our multicentric study reveals a substantial prevalence of tobacco use among TB patients, with cigarette smoking emerging as the predominant form. These findings underscore the imperative for implementing targeted cessation interventions within TB control programs. Special emphasis is warranted for male patients aged 25-59 years.
Databáze: MEDLINE